EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Immunometabolism of CD8+ T cell differentiation in cancer

Hao Shi, Sidi Chen, Hongbo Chi

Trends in Cancer · 2024-07 · 10 (7) · 610-626

DOI: 10.1016/j.trecan.2024.03.010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2024-07. Verfasst von Hao Shi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA. Hauptthemen laut MEDLINE: Cell Differentiation, Neoplasms, T-Lymphocytes, Cytotoxic, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS, Lupus Research Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CD8+ cytotoxic T lymphocytes (CTLs) are central mediators of tumor immunity and immunotherapies. Upon tumor antigen recognition, CTLs differentiate from naive/memory-like toward terminally exhausted populations with more limited function against tumors. Such differentiation is regulated by both immune signals, including T cell receptors (TCRs), co-stimulation, and cytokines, and metabolism-associated processes. These immune signals shape the metabolic landscape via signaling, transcriptional and post-transcriptional mechanisms, while metabolic processes in turn exert spatiotemporal effects to modulate the strength and duration of immune signaling. Here, we review the bidirectional regulation between immune signals and metabolic processes, including nutrient uptake and intracellular metabolic pathways, in shaping CTL differentiation and exhaustion. We also discuss the mechanisms underlying how specific nutrient sources and metabolite-mediated signaling events orchestrate CTL biology. Understanding how metabolic programs and their interplay with immune signals instruct CTL differentiation and exhaustion is crucial to uncover tumor-immune interactions and design novel immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell DifferentiationNeoplasmsT-Lymphocytes, CytotoxicCD8-Positive T-LymphocytesHumansSignal TransductionImmunotherapyAnimalsReceptors, Antigen, T-CellTumor Microenvironment

Stichwörter der Autor:innen

T cell differentiationTCRantitumor functioncytokinesexhaustionmitochondrial fitness

Substanzen

Receptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Department of Genetics, Yale University School of Medicine, New Haven, CT, USA; System Biology Institute, Integrated Science & Technology Center, West Haven, CT, USA. Electronic address: sidi.chen@yale.edu.
  • Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA. Electronic address: hongbo.chi@stjude.org.

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • Lupus Research Alliance
  • KAIST Creative Research Initiatives
  • National Institutes of Health
  • US Department of Defense
  • American Lebanese Syrian Associated Charities
  • National Cancer Institute

Zitieren

APA

Shi, H., Chen, S., & Chi, H. (2024). Immunometabolism of CD8+ T cell differentiation in cancer. Trends in Cancer, 10(7), 610-626. https://doi.org/10.1016/j.trecan.2024.03.010

Vancouver

Shi H, Chen S, Chi H. Immunometabolism of CD8+ T cell differentiation in cancer. Trends in Cancer. 2024;10(7):610-626. doi:10.1016/j.trecan.2024.03.010

BibTeX
@article{Shi2024,
  author = {Shi, Hao and Chen, Sidi and Chi, Hongbo},
  title = {Immunometabolism of CD8+ T cell differentiation in cancer},
  journal = {Trends in Cancer},
  year = {2024},
  volume = {10},
  number = {7},
  pages = {610--626},
  doi = {10.1016/j.trecan.2024.03.010}
}
Kostenlos starten →